• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe acute radiation-induced enterocolitis after combined palbociclib and palliative radiotherapy treatment.

作者信息

Kawamoto Terufumi, Shikama Naoto, Sasai Keisuke

机构信息

Graduate School of Medicine Department of Radiation Oncology, Juntendo University, Japan.

出版信息

Radiother Oncol. 2019 Feb;131:240-241. doi: 10.1016/j.radonc.2018.09.020. Epub 2018 Oct 15.

DOI:10.1016/j.radonc.2018.09.020
PMID:30336956
Abstract
摘要

相似文献

1
Severe acute radiation-induced enterocolitis after combined palbociclib and palliative radiotherapy treatment.哌柏西利与姑息性放疗联合治疗后发生的严重急性放射性小肠结肠炎。
Radiother Oncol. 2019 Feb;131:240-241. doi: 10.1016/j.radonc.2018.09.020. Epub 2018 Oct 15.
2
Preliminary results of the association of Palbociclib and radiotherapy in metastatic breast cancer patients.帕博西尼与放疗联合用于转移性乳腺癌患者的初步结果。
Radiother Oncol. 2018 Jan;126(1):181. doi: 10.1016/j.radonc.2017.09.010. Epub 2017 Sep 27.
3
[Treatment Experience of Palbociclib as a New Checkpoint Inhibitor].[哌柏西利作为新型检查点抑制剂的治疗经验]
Gan To Kagaku Ryoho. 2018 Oct;45(10):1498-1500.
4
Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval.帕博西尼处方模式的真实世界证据分析：美国社区肿瘤实践中批准上市后一年治疗晚期/转移性乳腺癌患者。
Breast Cancer Res. 2018 May 2;20(1):37. doi: 10.1186/s13058-018-0958-2.
5
Treatment satisfaction in women receiving palbociclib combination therapies for advanced/metastatic breast cancer.接受帕博西尼联合治疗的晚期/转移性乳腺癌女性的治疗满意度。
Future Oncol. 2019 Jan;15(2):141-150. doi: 10.2217/fon-2018-0531. Epub 2018 Sep 12.
6
Verapamil as a culprit of palbociclib toxicity.维拉帕米作为哌柏西利毒性的罪魁祸首。
J Oncol Pharm Pract. 2019 Apr;25(3):743-746. doi: 10.1177/1078155218761798. Epub 2018 Mar 9.
7
The safety of palbociclib for the treatment of advanced breast cancer.帕博西尼治疗晚期乳腺癌的安全性。
Expert Opin Drug Saf. 2018 Mar;17(3):325-330. doi: 10.1080/14740338.2018.1429402. Epub 2018 Jan 28.
8
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.帕博西尼联合氟维司群治疗绝经前激素受体阳性晚期乳腺癌患者的效果：PALOMA-3 研究结果
Oncologist. 2017 Sep;22(9):1028-1038. doi: 10.1634/theoncologist.2017-0072. Epub 2017 Jun 26.
9
Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.帕博西尼诱发转移性乳腺癌患者血栓性微血管病并存活18年：病例报告及文献综述
Clin Breast Cancer. 2018 Jun;18(3):e263-e266. doi: 10.1016/j.clbc.2017.10.001. Epub 2017 Oct 7.
10
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.哌柏西利联合氟维司群治疗晚期乳腺癌的总生存期
N Engl J Med. 2018 Nov 15;379(20):1926-1936. doi: 10.1056/NEJMoa1810527. Epub 2018 Oct 20.

引用本文的文献

1
Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation.依达拉奉对小鼠肠道损伤具有保护作用，且不干扰辐射的抗肿瘤效应。
Curr Issues Mol Biol. 2023 Jun 28;45(7):5362-5372. doi: 10.3390/cimb45070340.
2
Safety of CDK4/6 Inhibitors Combined with Radiotherapy in Patients with Metastatic Breast Cancer: A Review of the Literature.CDK4/6 抑制剂联合放疗治疗转移性乳腺癌患者的安全性：文献复习。
Curr Oncol. 2023 Jun 6;30(6):5485-5496. doi: 10.3390/curroncol30060415.
3
Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer.
放射治疗联合CDK 4/6抑制剂治疗晚期乳腺癌的安全性与可行性
Cancers (Basel). 2023 Jan 22;15(3):690. doi: 10.3390/cancers15030690.
4
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study.使用剂量体积参数分析的转移性乳腺癌联合放疗与CDK4/6抑制剂治疗非血液学毒性的发生率及危险因素：一项多中心队列研究
Breast Cancer. 2023 Mar;30(2):282-292. doi: 10.1007/s12282-022-01422-5. Epub 2022 Dec 17.
5
Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies.在不断发展的全身治疗、免疫治疗和靶向治疗时代，转移灶定向放射治疗的安全性和耐受性
Adv Radiat Oncol. 2022 Jul 14;7(6):101022. doi: 10.1016/j.adro.2022.101022. eCollection 2022 Nov-Dec.
6
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process.非脊柱骨转移瘤的多学科治疗：改良德尔菲共识流程的结果
Clin Transl Radiat Oncol. 2022 Apr 26;35:76-83. doi: 10.1016/j.ctro.2022.04.009. eCollection 2022 Jul.
7
The role of radiation therapy and systemic therapies in elderly with breast cancer.放射治疗和全身治疗在老年乳腺癌患者中的作用。
Transl Cancer Res. 2020 Jan;9(Suppl 1):S97-S109. doi: 10.21037/tcr.2019.07.04.
8
Novel Combinatorial Strategy Using Thermal Inkjet Bioprinting, Chemotherapy, and Radiation on Human Breast Cancer Cells; an In-Vitro Cell Viability Assessment.使用热喷墨生物打印、化疗和放疗对人乳腺癌细胞的新型联合策略；体外细胞活力评估。
Materials (Basel). 2021 Dec 19;14(24):7864. doi: 10.3390/ma14247864.
9
Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management.现代放射疗法与新型靶向治疗联合用于乳腺癌管理
Cancers (Basel). 2021 Dec 18;13(24):6358. doi: 10.3390/cancers13246358.
10
Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.细胞周期蛋白依赖性激酶抑制剂（CDKI）与放疗（RT）联合应用在转移性乳腺癌（MBC）治疗中的作用：临床实践中的优势与风险
Front Oncol. 2021 Jun 17;11:643155. doi: 10.3389/fonc.2021.643155. eCollection 2021.